Drug Shortage Report for LIPIDIL SUPRA
Report ID | 166046 |
Drug Identification Number | 02241602 |
Brand name | LIPIDIL SUPRA |
Common or Proper name | LIPIDIL SUPRA |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | FENOFIBRATE |
Strength(s) | 160MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 3x10 |
ATC code | C10AB |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-10-05 |
Actual start date | |
Estimated end date | 2022-10-11 |
Actual end date | 2022-08-15 |
Shortage status | Avoided shortage |
Updated date | 2022-08-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-08-15 | French | Compare |
v3 | 2022-08-15 | English | Compare |
v2 | 2022-08-03 | French | Compare |
v1 | 2022-08-03 | English | Compare |
Showing 1 to 4 of 4